Cargando…

NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes

Type 2 diabetes mellitus (T2DM), accounting for 90–95% cases of diabetes, is characterized by chronic inflammation. The mechanisms that control inflammation activation in T2DM are largely unexplored. Inflammasomes represent significant sensors mediating innate immune responses. The aim of this work...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gora, Ilona M., Ciechanowska, Anna, Ladyzynski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913585/ https://www.ncbi.nlm.nih.gov/pubmed/33546399 http://dx.doi.org/10.3390/cells10020314

Ejemplares similares

The Effect of High and Variable Glucose on the Viability of Endothelial Cells Co-Cultured with Smooth Muscle Cells
por: Ciechanowska, Anna, et al.
Publicado: (2022)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

Mitochondrial DNA Promotes NLRP3 Inflammasome Activation and Contributes to Endothelial Dysfunction and Inflammation in Type 1 Diabetes
por: Pereira, Camila A., et al.
Publicado: (2020)

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
por: Wan, Zhaofei, et al.
Publicado: (2019)

Inflammation triggered by the NLRP3 inflammasome is a critical driver of diabetic bladder dysfunction
por: Hughes, Francis M., et al.
Publicado: (2022)

NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus
por: Ferreira, Nathanne Santos, et al.
Publicado: (2019)

Protection by simvastatin on hyperglycemia-induced endothelial dysfunction through inhibiting NLRP3 inflammasomes
por: Lv, Zhen-Huan, et al.
Publicado: (2017)

Neutrophil Extracellular Traps Promote NLRP3 Inflammasome Activation and Glomerular Endothelial Dysfunction in Diabetic Kidney Disease
por: Gupta, Anubhuti, et al.
Publicado: (2022)

The cardiac glycoside ouabain activates NLRP3 inflammasomes and promotes cardiac inflammation and dysfunction
por: Kobayashi, Motoi, et al.
Publicado: (2017)

Sinapine Thiocyanate Ameliorates Vascular Endothelial Dysfunction in Hypertension by Inhibiting Activation of the NLRP3 Inflammasome
por: Liu, Yang, et al.
Publicado: (2021)

Kakonein restores diabetes‐induced endothelial junction dysfunction via promoting autophagy‐mediated NLRP3 inflammasome degradation
por: Lian, Dawei, et al.
Publicado: (2021)

The NLRP3–inflammasome as a sensor of organelle dysfunction
por: Seoane, Paula I., et al.
Publicado: (2020)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

Wound Area Measurement with Digital Planimetry: Improved Accuracy and Precision with Calibration Based on 2 Rulers
por: Foltynski, Piotr, et al.
Publicado: (2015)

Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
por: Lee, Hye-Mi, et al.
Publicado: (2013)

Nlrp3 Inflammasome Activation in Type 2 Diabetes: Is It Clinically Relevant?
por: Dixit, Vishwa Deep
Publicado: (2013)

Humanin Ameliorates Free Fatty Acid-Induced Endothelial Inflammation by Suppressing the NLRP3 Inflammasome
por: Li, Wenfeng, et al.
Publicado: (2020)

NLRP3 Inflammasome-Mediated Inflammation in Acute Pancreatitis
por: Ferrero-Andrés, Ana, et al.
Publicado: (2020)

The NLRP3 inflammasome: contributions to inflammation-related diseases
por: Chen, Ying, et al.
Publicado: (2023)

Sterile inflammation and the NLRP3 inflammasome in cardiometabolic disease
por: Cho, Sungji, et al.
Publicado: (2023)

Cold-inducible RNA-binding protein causes endothelial dysfunction via activation of Nlrp3 inflammasome
por: Yang, Weng-Lang, et al.
Publicado: (2016)

Qiqilian ameliorates vascular endothelial dysfunction by inhibiting NLRP3-ASC inflammasome activation in vivo and in vitro
por: Luo, Yuan, et al.
Publicado: (2023)

Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes
por: Ding, Sujuan, et al.
Publicado: (2019)

NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients
por: Klen, Jasna, et al.
Publicado: (2015)

The role of NLRP3 inflammasome for microglial response to peripheral inflammation
por: Garaschuk, Olga
Publicado: (2020)

Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome
por: Chang, Yu-Wei, et al.
Publicado: (2021)

Insulin in Type 1 and Type 2 Diabetes—Should the Dose of Insulin Before a Meal be Based on Glycemia or Meal Content?
por: Krzymien, Janusz, et al.
Publicado: (2019)

The NLRP3-Inflammasome in Health and Disease
por: Perri, Anna
Publicado: (2022)

Induction of NLRP3 Inflammasome Activation by Heme in Human Endothelial Cells
por: Erdei, Judit, et al.
Publicado: (2018)

Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy
por: Zhao, Wenli, et al.
Publicado: (2022)

NLRP3 Inflammasome in Diabetic Cardiomyopathy and Exercise Intervention
por: Sun, Yi, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
por: Zhang, Lei, et al.
Publicado: (2022)

The Role of H(2)S Regulating NLRP3 Inflammasome in Diabetes
por: Zhao, Huijie, et al.
Publicado: (2022)

Myo‐inositol oxygenase (MIOX) accelerated inflammation in the model of infection‐induced cardiac dysfunction by NLRP3 inflammasome
por: Zhou, Wenjun, et al.
Publicado: (2023)

Lespedeza bicolor Extract Ameliorated Renal Inflammation by Regulation of NLRP3 Inflammasome-Associated Hyperinflammation in Type 2 Diabetic Mice
por: Park, Ji Eun, et al.
Publicado: (2020)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Exposure to Dengue Envelope Protein Domain III Induces Nlrp3 Inflammasome-Dependent Endothelial Dysfunction and Hemorrhage in Mice
por: Lien, Te-Sheng, et al.
Publicado: (2021)

Pharmacological Blockade of NLRP3 Inflammasome/IL-1β-Positive Loop Mitigates Endothelial Cell Senescence and Dysfunction
por: Romero, Alejandra, et al.
Publicado: (2022)

Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation
por: Yu, Xianjun, et al.
Publicado: (2017)

An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes
por: Raneros, Aroa Baragaño, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_okdsg94hq7djo2hnfml33uvprd